Company Filing History:
Years Active: 2020-2024
Title: Karsten Weber: Innovator in Breast Cancer Prognosis
Introduction
Karsten Weber is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medical technology, particularly in breast cancer prognosis. With a total of 3 patents, his work focuses on improving the accuracy of disease outcome predictions for breast cancer patients.
Latest Patents
One of Karsten Weber's latest patents is a method for breast cancer recurrence prediction under endocrine treatment. This invention relates to methods, kits, and systems designed to assess the prognosis of breast cancer outcomes. The method involves determining the RNA expression levels of at least two of nine specific genes in a tumor sample. These genes include UBE2C, BIRC5, RACGAP1, DHCR7, STC2, AZGP1, RBBP8, IL6ST, and MGP. The expression level values are mathematically combined to yield a score that indicates the prognosis for the patient.
Career Highlights
Throughout his career, Karsten Weber has worked with several prominent companies in the medical field. Notably, he has been associated with Myriad International GmbH and Sividon Diagnostics GmbH. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer prognosis.
Collaborations
Karsten has collaborated with several professionals in his field, including Mareike Dartmann and Inke Sabine Feder. These collaborations have further enhanced his research and development efforts in breast cancer prognosis.
Conclusion
Karsten Weber's contributions to breast cancer prognosis through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to influence the medical technology landscape, making a significant impact on cancer treatment and prognosis.